The Gene Polymorphism of VMAT2 Is Associated with Risk of Schizophrenia in Male Han Chinese

키워드

참고문헌 (36)

1. Ayhan Y, "Animal models of gene-environment interactions in schizophrenia", Behav Brain Res, 204, pp.274~281 (2009)
2. Schizophrenia Working Group of the Psychiatric Genomics Consortium, "Biological insights from 108 schizophrenia-associated genetic loci", Nature, 511, pp.421~427 (2014)
3. Ripke S, "Genome-wide association analysis identifies 13 new risk loci for schizophrenia", Nat Genet, 45, pp.1150~1159 (2013)
4. Harrison PJ, "Recent genetic findings in schizophrenia and their therapeutic relevance", J Psychopharmacol, 29, pp.85~96 (2015)
5. Williams NM, "A systematic genomewide linkage study in 353 sib pairs with schizophrenia", Am J Hum Genet, 73, pp.1355~1367 (2003)
6. de Natale ER, "International Review of Neurobiology", pp.131~172 (2018), Academic Press
7. Brighina L, "Analysis of vesicular monoamine transporter 2 polymorphisms in Parkinson’s disease", Neurobiol Aging, 34, pp.1712~1719 (2013)
8. Da SAF, "The revised dopamine hypothesis of schizophrenia : evidence from pharmacological MRI studies with atypical antipsychotic medication", Psychopharmacol Bull, 41, pp.121~132 (2008)
9. He X, "Association studies of MMP-9 in Parkinson’s disease and amyotrophic lateral sclerosis", PLos One, 8, pp.e73777~ (2013)
10. Han H, "The C(-1562)T polymorphism of matrix metalloproteinase-9 gene is associated with schizophrenia in China", Psychiatry Res, 190, pp.163~164 (2011)
11. Ira E, "COMT, neuropsychological function and brain structure in schizophrenia : a systematic review and neurobiological interpretation", J Psychiatry Neurosci, 38, pp.366~380 (2013)
12. Kiyohara C, "Genetic polymorphisms involved in dopaminergic neurotransmission and risk for Parkinson’s disease in a Japanese population", BMC Neurol, 11, pp.89~ (2011)
13. Carrera N, "Recent adaptive selection at MAOB and ancestral susceptibility to schizophrenia", Am J Med Genet B Neuropsychiatr Genet, 150B, pp.369~374 (2009)
14. First MB, "Clinician Version(SCID-CV)" (1996), American Psychiatric Press, Inc
15. Rapoport JL, "The neurodevelopmental model of schizophrenia : update 2005", Mol Psychiatry, 10, pp.434~449 (2005)
16. Thomas G, "Capillary and microelectrophoretic separations of ligase detection reaction products produced from low-abundant point mutations in genomic DNA", Electrophoresis, 25, pp.1668~1677 (2004)
17. Talkowski ME, "A network of dopaminergic gene variations implicated as risk factors for schizophrenia", Hum Mol Genet, 17, pp.747~758 (2008)
18. Lin Z, "SLC18A2 promoter haplotypes and identification of a novel protective factor against alcoholism", Hum Mol Genet, 14, pp.1393~1404 (2005)
19. Taylor SF, "In vivo measurement of the vesicular monoamine transporter in schizophrenia", Neuropsychopharmacology, 23, pp.667~675 (2000)
20. Zubieta JK, "Vesicular monoamine transporter concentrations in bipolar disorder type I, schizophrenia, and healthy subjects", Biol Psychiatry, 49, pp.110~116 (2001)
21. Volz TJ, "Agedependent differences in dopamine transporter and vesicular monoamine transporter-2 function and their implications for methamphetamine neurotoxicity", Synapse, 63, pp.147~151 (2009)
22. Zucker M, "Increased platelet vesicular monoamine transporter density in adult schizophrenia patients", Eur Neuropsychopharmacol, 12, pp.343~347 (2002)
23. Iritani S, "Immunohistochemical study of vesicle monoamine transporter 2 in the hippocampal region of genetic animal model of schizophrenia", Synapse, 64, pp.948~953 (2010)
24. Simons CJ, "Intermediate phenotype analysis of patients, unaffected siblings, and healthy controls identifies VMAT2 as a candidate gene for psychotic disorder and neurocognition", Schizophr Bull, 39, pp.848~856 (2013)
25. Li Q, "Genetic variations in the 3’-untranslated region of SLC18A2 are associated with serum FSH concentration in polycystic ovary syndrome patients and regulate gene expression in vitro", Hum Reprod, 31, pp.2150~2157 (2016)
26. Bharadwaj RA, "Genetic risk mechanisms of posttraumatic stress disorder in the human brain", J Neurosci Res, 96, pp.21~30 (2018)
27. Bergen SE, "Genetic modifiers and subtypes in schizophrenia : investigations of age at onset, severity, sex and family history", Schizophr Res, 154, pp.48~53 (2014)
28. Ben NM, "A gender-specific association of interleukin 1 receptor antagonist polymorphism with schizophrenia susceptibility", Acta Neuropsychiatr, 25, pp.349~355 (2013)
29. Zhang X, "The type 2 diabetes mellitus susceptibility gene IGF2BP2 is associated with schizophrenia in a Han Chinese population", J Clin Psychiatry, 74, pp.e287~e292 (2013)
30. Xie C, "Association between schizophrenia and single nucleotide polymorphisms in lipoprotein lipase gene in a Han Chinese population", Psychiatr Genet, 21, pp.307~314 (2011)
31. Carroll LS, "Evidence for rare and common genetic risk variants for schizophrenia at protein kinase C, alpha", Mol Psychiatry, 15, pp.1101~1111 (2010)
32. Wang LW, "Association between ESR1 gene polymorphisms and haplotypes with schizophrenia", Zhonghua Yi Xue Yi Chuan Xue Za Zhi, 30, pp.21~25 (2013)
33. Ma H, "Association between neurotensin receptor 1(NTR1)gene polymorphisms and schizo-phrenia in a Han Chinese population", J Mol Neurosci, 50, pp.345~352 (2013)
34. Shifman S, "Genome-wide association identifies a common variant in the reelin gene that increases the risk of schizophrenia only in women", PLos Genet, 4, pp.e28~ (2008)
35. Chen Q, "Is the histidine triad nucleotide-binding protein 1(HINT1)gene a candidate for schizophrenia", Schizophr Res, 106, pp.200~207 (2008)
36. Zai CC, "Association study of the vesicular monoamine transporter gene SLC18A2 with tardive dyskinesia", J Psychiatr Res, 47, pp.1760~1765 (2013)

관련 논문AI추천